- Report
- January 2026
- 501 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 466 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 385 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 282 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 363 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 277 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 478 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 383 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 281 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 191 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 217 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 199 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 173 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 193 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 168 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 193 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 194 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- January 2026
- 173 Pages
Global
From €5078EUR$5,850USD£4,402GBP
- Report
- July 2025
- 150 Pages
Global
From €3255EUR$3,750USD£2,822GBP
- Report
- January 2026
- 111 Pages
Global
From €4123EUR$4,750USD£3,575GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more